{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:48:43Z","timestamp":1790743723070,"version":"4.1.0"},"reference-count":294,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.imbio.2023.152393","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:01:15Z","timestamp":1683824475000},"page":"152393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-3550","authenticated-orcid":false,"given":"Wioleta M.","family":"Zelek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0005","doi-asserted-by":"crossref","first-page":"e00281","DOI":"10.1128\/mBio.00281-21","article-title":"COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions","volume":"12","author":"Adeniji","year":"2021","journal-title":"MBio"},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0010","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease","volume":"89","author":"Agrawal","year":"2015","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/bloodadvances.2021005246","article-title":"C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19","volume":"6","author":"Aiello","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.imbio.2023.152393_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714511","article-title":"Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins","volume":"12","author":"Ali","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841759","article-title":"Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19","volume":"13","author":"Ali","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0030","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1007\/s10072-022-06108-6","article-title":"A mild course of COVID-19 infection in a generalized Myasthenia gravis patient under eculizumab treatment","volume":"43","author":"Alis","year":"2022","journal-title":"Neurol Sci."},{"key":"10.1016\/j.imbio.2023.152393_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668725","article-title":"Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality","volume":"12","author":"Alosaimi","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40629-021-00177-3","article-title":"Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines","volume":"30","author":"Altrichter","year":"2021","journal-title":"Allergo J Int."},{"key":"10.1016\/j.imbio.2023.152393_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100590","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study","volume":"28","author":"Annane","year":"2020","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.imbio.2023.152393_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834988","article-title":"Signaling Through Fc\u03b3RIIA and the C5a\u2013C5aR Pathway Mediate Platelet Hyperactivation in COVID-19","volume":"13","author":"Apostolidis","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0055","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/jcmm.17098","article-title":"Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks","volume":"26","author":"Asteris","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0060","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1002\/hsr2.519","article-title":"Elevated levels of C3, C4, and CH50 of the complement system in ICU and non-ICU patients with COVID-19","volume":"5","author":"Bagherimoghaddam","year":"2022","journal-title":"Heal Sci. Rep."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0065","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bjh.17558","article-title":"COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey","volume":"194","author":"Barcellini","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/1744-9987.13710","article-title":"Additional eculizumab dose and tacrolimus discontinuation for treatment of COVID-19 in a kidney transplant recipient with aHUS","volume":"26","author":"Ba\u0161i\u0107-Juki\u0107","year":"2022","journal-title":"Ther. Apher. Dial."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41577-021-00634-8","article-title":"Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation","volume":"22","author":"Bekassy","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2022.104111","article-title":"The enigma of the 1889 Russian flu pandemic: A coronavirus?","volume":"51","author":"Berche","year":"2022","journal-title":"Presse Med."},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b0085","first-page":"e27962","article-title":"COVID-19: A Rare Cause of Hemolytic Uremic Syndrome","volume":"14","author":"Boldig","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1081-1206(10)60424-3","article-title":"Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients","volume":"100","author":"Bork","year":"2008","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2021.11.004","article-title":"Severe COVID-19 is associated with hyperactivation of the alternative complement pathway","volume":"149","author":"Boussier","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0100","doi-asserted-by":"crossref","first-page":"1056153","DOI":"10.3389\/fimmu.2022.1056153","article-title":"COVID-19 vaccination and Atypical hemolytic uremic syndrome","volume":"13","author":"Bouwmeester","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0105","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1515\/cclm-2021-0694","article-title":"Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19","volume":"59","author":"Brasen","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.imbio.2023.152393_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941742","article-title":"Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study","volume":"13","author":"Bruni","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b0115","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/1751-7915.13916","article-title":"What we can learn from the dynamics of the 1889 \u201cRussian flu\u201d pandemic for the future trajectory of COVID-19","volume":"14","author":"Br\u00fcssow","year":"2021","journal-title":"J. Microbial. Biotechnol."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0120","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/1751-7915.13889","article-title":"Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic","volume":"14","author":"Br\u00fcssow","year":"2021","journal-title":"J. Microbial. Biotechnol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0125","doi-asserted-by":"crossref","first-page":"e13559","DOI":"10.1111\/aji.13559","article-title":"Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series","volume":"88","author":"Burwick","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0130","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1007\/s00415-021-10578-7","article-title":"COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica","volume":"268","author":"Cabal-Herrera","year":"2021","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.imbio.2023.152393_b0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat. Immunol."},{"issue":"7836","key":"10.1016\/j.imbio.2023.152393_b0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0145","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1097\/CCM.0000000000005683","article-title":"Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])","volume":"50","author":"Carvelli","year":"2022","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0150","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: a comprehensive review","volume":"54","author":"Castanares-Zapatero","year":"2022","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0155","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/jiac091","article-title":"Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019","volume":"226","author":"Castanha","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0160","first-page":"437","article-title":"Breakthrough haemolysis in paroxysmal nocturnal haemoglobinuria after COVID-19 infection and COVID vaccination: what is worse?","volume":"20","author":"Cavallaro","year":"2022","journal-title":"Blood Transfus."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b0165","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/medicina57111163","article-title":"Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis","volume":"57","author":"Chang","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.imbio.2023.152393_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.765330","article-title":"Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study","volume":"12","author":"Charitos","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0175","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: A collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s10020-021-00422-z","article-title":"Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection","volume":"27","author":"Chen","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.imbio.2023.152393_b0185","doi-asserted-by":"crossref","unstructured":"Cheng W, Hornung R, Xu K, Yang C hong, Li J. Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China. Sci Rep. 2021;11(1):7857.","DOI":"10.1038\/s41598-021-82810-3"},{"key":"10.1016\/j.imbio.2023.152393_b0190","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2147\/JBM.S324873","article-title":"A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab","volume":"12","author":"Chidharla","year":"2021","journal-title":"J. Blood Med."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/jcm12010109","article-title":"Genome-Wide Pleiotropy Study Identifies Association of PDGFB with Age-Related Macular Degeneration and COVID-19 Infection Outcomes","volume":"12","author":"Chung","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.imbio.2023.152393_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845496","article-title":"Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination","volume":"13","author":"Cirillo","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.ajkd.2022.07.012","article-title":"Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report","volume":"81","author":"Claes","year":"2023","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0210","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40620-021-01057-3","article-title":"COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report","volume":"34","author":"Cognard","year":"2021","journal-title":"J. Nephrol."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0215","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/biomedicines9121931","article-title":"Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-\u03b2 but Higher Levels of IL-1\u03b1 and TGF-\u03b2","volume":"9","author":"Colarusso","year":"2021","journal-title":"Biomedicines."},{"issue":"1\u20132","key":"10.1016\/j.imbio.2023.152393_b0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virusres.2009.03.017","article-title":"Absence of antibody-dependent, complement-mediated lysis of feline infectious peritonitis virus-infected cells","volume":"144","author":"Cornelissen","year":"2009","journal-title":"Virus Res."},{"issue":"14","key":"10.1016\/j.imbio.2023.152393_b0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM197704072961401","article-title":"Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis","volume":"296","author":"Craddock","year":"1977","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0230","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s10067-021-05580-3","article-title":"Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies","volume":"40","author":"Cristiano","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: A novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102560","article-title":"Complement activation and endothelial perturbation parallel COVID-19 severity and activity","volume":"116","author":"Cugno","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2023.152393_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102728","article-title":"Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"124","author":"Cugno","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2023.152393_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.707159","article-title":"Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population","volume":"12","author":"Cyprian","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b0255","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.gim.2022.04.007","article-title":"Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals","volume":"24","author":"D\u2019Alterio","year":"2022","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0265","doi-asserted-by":"crossref","first-page":"e242937","DOI":"10.1136\/bcr-2021-242937","article-title":"Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab","volume":"15","author":"Dawudi","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.imbio.2023.152393_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.879157","article-title":"Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia","volume":"13","author":"de Buhr","year":"2022","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.imbio.2023.152393_b0275","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0280","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","article-title":"Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes","volume":"223","author":"De Nooijer","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2023.152393_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.742446","article-title":"Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality","volume":"12","author":"Defendi","year":"2021","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.imbio.2023.152393_b0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2011.08.006","article-title":"MAp19, the alternative splice product of the MASP2 gene","volume":"373","author":"Degn","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2023.152393_b0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-030-63761-3_7","article-title":"Genetic Polymorphisms in the Host and COVID-19 Infection","volume":"1318","author":"Delanghe","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0300","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/life12091335","article-title":"C3a and C5b\u20139 Differentially Predict COVID-19 Progression and Outcome","volume":"12","author":"Detsika","year":"2022","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2022.105081","article-title":"Association of complement pathways with COVID-19 severity and outcomes","volume":"25","author":"Devalaraja-Narashimha","year":"2023","journal-title":"Microbes Infect."},{"key":"10.1016\/j.imbio.2023.152393_b0310","doi-asserted-by":"crossref","unstructured":"D\u00e9zsi L, M\u00e9sz\u00e1ros T, Kozma G, H-Velkei M, Ol\u00e1h CZ, Szab\u00f3 M, et al., 2022. A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor. GeroScience 44(2):597\u2013618.","DOI":"10.1007\/s11357-021-00495-y"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0315","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b0320","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1172\/JCI140970","article-title":"Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2","volume":"130","author":"Diorio","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0325","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.imbio.2023.152393_b0330","doi-asserted-by":"crossref","first-page":"1002652","DOI":"10.3389\/fimmu.2022.1002652","article-title":"C-reactive protein, immunothrombosis and venous thromboembolism","volume":"13","author":"Dix","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0335","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1055\/s-0040-1715835","article-title":"Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients","volume":"120","author":"Eriksson","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0340","doi-asserted-by":"crossref","first-page":"e19588","DOI":"10.2196\/19588","article-title":"Nomogram for Predicting COVID-19 Disease Progression Based on Single-Center Data: Observational Study and Model Development","volume":"8","author":"Fan","year":"2020","journal-title":"JMIR Med informatics."},{"issue":"Pt A","key":"10.1016\/j.imbio.2023.152393_b0345","article-title":"Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study","volume":"89","author":"Fang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110114","article-title":"Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern","volume":"37","author":"Farkash","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000519461","article-title":"Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3\/CFHR1 Gene Deletion","volume":"146","author":"Ferrer","year":"2022","journal-title":"Nephron"},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b0360","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1016\/j.jaip.2021.08.039","article-title":"COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema","volume":"9","author":"Fijen","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112189","article-title":"SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice","volume":"42","author":"Fontes-Dantas","year":"2023","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0370","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12185-022-03324-w","article-title":"COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm","volume":"115","author":"Fujimura","year":"2022","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0375","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41392-022-01133-5","article-title":"Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0380","doi-asserted-by":"crossref","first-page":"e64443","DOI":"10.1371\/journal.pone.0064443","article-title":"Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury","volume":"8","author":"Garcia","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0385","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.1988.tb02354.x","article-title":"Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3","volume":"27","author":"Garred","year":"1988","journal-title":"Scand. J. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0390","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11239-021-02617-x","article-title":"Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease","volume":"53","author":"Gauchel","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.imbio.2023.152393_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108726","article-title":"Genetic justification of severe COVID-19 using a rigorous algorithm","volume":"226","author":"Gavriilaki","year":"2021","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0400","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.3390\/cimb44070193","article-title":"Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection","volume":"44","author":"Gavriilaki","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-022-01313-y","article-title":"Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients","volume":"10","author":"Genchi","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b0410","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1080\/10428194.2020.1869963","article-title":"Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy","volume":"62","author":"Genthon","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0415","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","article-title":"Complement activation induces excessive T cell cytotoxicity in severe COVID-19","volume":"185","author":"Georg","year":"2022","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.imbio.2023.152393_b0420","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1182\/blood.2021011548","article-title":"COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria","volume":"137","author":"Gerber","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0425","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40620-021-01125-8","article-title":"COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy","volume":"35","author":"Gill","year":"2022","journal-title":"J. Nephrol."},{"key":"10.1016\/j.imbio.2023.152393_b0430","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fphar.2020.00857","article-title":"Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study","volume":"11","author":"Giudice","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.imbio.2023.152393_b0435","first-page":"1","article-title":"Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19","volume":"11","author":"G\u00f6tz","year":"2022","journal-title":"J. Innate Immun."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0440","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0445","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2009.03200.x","article-title":"Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot","volume":"129","author":"Gulla","year":"2010","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0450","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41467-021-23494-1","article-title":"SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care","volume":"12","author":"Gutmann","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0455","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10875-021-01061-z","article-title":"Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality","volume":"41","author":"Hamed","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0460","doi-asserted-by":"crossref","unstructured":"Hammerschmidt DE, Hudson LD, Weaver LJ, Craddock PR, Jacob HS. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (London, England). 1980;1(8175):947\u20139.","DOI":"10.1016\/S0140-6736(80)91403-8"},{"key":"10.1016\/j.imbio.2023.152393_b0465","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/VHRM.S299357","article-title":"COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on \u201cTwo-Path Unifying Theory\u201d of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy","volume":"17","author":"Hang","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0470","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciac705","article-title":"Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases","volume":"76","author":"Harrigan","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.imbio.2023.152393_b0475","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2012.06.001","article-title":"The complotype: dictating risk for inflammation and infection","volume":"33","author":"Harris","year":"2012","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0480","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00281-017-0661-x","article-title":"The properdin pathway: an \u201calternative activation pathway\u201d or a \u201ccritical amplification loop\u201d for C3 and C5 activation?","volume":"40","author":"Harrison","year":"2018","journal-title":"Semin. Immunopathol."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0485","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/jim-2021-002224","article-title":"Prognostic significance of complement factors in severely ill patients with COVID-19","volume":"70","author":"Hassan","year":"2022","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.imbio.2023.152393_b0490","doi-asserted-by":"crossref","unstructured":"Hayes B, Stanley J, Peppers BP. COVID-19 Recurrence Without Seroconversion in a Patient With Mannose-Binding Lectin Deficiency. Allergy Rhinol (Providence). 2021; 12:21526567211024140.","DOI":"10.1177\/21526567211024140"},{"issue":"26","key":"10.1016\/j.imbio.2023.152393_b0495","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1073\/pnas.1202588109","article-title":"Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2","volume":"109","author":"H\u00e9ja","year":"2012","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0500","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1002\/jmv.27077","article-title":"Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state","volume":"93","author":"Henry","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imbio.2023.152393_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.796109","article-title":"Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study","volume":"9","author":"Henry","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.imbio.2023.152393_b0510","doi-asserted-by":"crossref","first-page":"9339411","DOI":"10.1155\/2022\/9339411","article-title":"Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019- (COVID-19-) Associated Acute Kidney Injury","volume":"2022","author":"Henry","year":"2022","journal-title":"Mediators Inflamm."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0515","doi-asserted-by":"crossref","first-page":"e252309","DOI":"10.1136\/bcr-2022-252309","article-title":"Optic neuromyelitis after vaccination against SARS-CoV-2","volume":"15","author":"Hernandez-Vega","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0520","doi-asserted-by":"crossref","first-page":"e35690","DOI":"10.1371\/journal.pone.0035690","article-title":"Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation","volume":"7","author":"Hess","year":"2012","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.imbio.2023.152393_b0525","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0530","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI109866","article-title":"Role of complement activation in a model of adult respiratory distress syndrome","volume":"66","author":"Hosea","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2023.152393_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748566","article-title":"Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study","volume":"12","author":"Hou","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0540","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/v13122376","article-title":"Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections","volume":"13","author":"Huber","year":"2021","journal-title":"Viruses"},{"issue":"1039765","key":"10.1016\/j.imbio.2023.152393_b0545","article-title":"Distinction of early complement classical and lectin pathway activation via quantification of C1s\/C1-INH and MASP-1\/C1-INH complexes using novel ELISAs","volume":"13","author":"Hurler","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0550","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.imbio.2023.152393_b0555","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/429631","article-title":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection","volume":"191","author":"Ip","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"79","key":"10.1016\/j.imbio.2023.152393_b0560","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b0565","doi-asserted-by":"crossref","first-page":"8626","DOI":"10.4049\/jimmunol.177.12.8626","article-title":"Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway","volume":"177","author":"Iwaki","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108795","article-title":"Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19","volume":"229","author":"Jamaly","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767981","article-title":"SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation","volume":"12","author":"Jarlhelt","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0580","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12519-021-00440-1","article-title":"Characteristics of immune and inflammatory responses among different age groups of pediatric patients with COVID-19 in China","volume":"17","author":"Ji","year":"2021","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.imbio.2023.152393_b0585","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2147\/IJGM.S348519","article-title":"Association of Complement C3 with Clinical Deterioration Among Hospitalized Patients with COVID-19","volume":"15","author":"Jiang","year":"2022","journal-title":"Int J Gen Med."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0590","article-title":"Blockade of the C5a\u2013C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg","volume":"7","author":"Jiang","year":"2018","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/v11010039","article-title":"Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV","volume":"11","author":"Jiang","year":"2019","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0600","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ps\/82.2.235","article-title":"Serum levels of mannan-binding lectin in chickens prior to and during experimental infection with avian infectious bronchitis virus","volume":"82","author":"Juul-Madsen","year":"2003","journal-title":"Poult. Sci."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0605","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/vim.2007.0036","article-title":"Mannan-binding lectin (MBL) serum concentration in relation to propagation of infectious bronchitis virus (IBV) in chickens","volume":"20","author":"Juul-Madsen","year":"2007","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0610","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12185-022-03387-9","article-title":"Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria","volume":"116","author":"Kamura","year":"2022","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.imbio.2023.152393_b0615","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijid.2022.02.031","article-title":"Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report","volume":"117","author":"Kamura","year":"2022","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0620","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaci.2020.10.025","article-title":"Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients","volume":"147","author":"Kaplan","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0625","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s13337-021-00710-6","article-title":"sssssPatients with Covid 19 have significantly reduced CH50 activity","volume":"32","author":"Keshavarz","year":"2021","journal-title":"Virusdisease."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0630","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s13337-021-00710-6","article-title":"Patients with Covid 19 have significantly reduced CH50 activity","volume":"32","author":"Keshavarz","year":"2021","journal-title":"Virusdisease."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0635","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00467-021-05390-4","article-title":"Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection","volume":"37","author":"Khandelwal","year":"2022","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109798","article-title":"Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19","volume":"37","author":"Kim","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152093","article-title":"Acquired decrease of the C3b\/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients","volume":"226","author":"Kisserli","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152393_b0650","unstructured":"Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv Prepr Serv Heal Sci. 2022;2022.08.09.22278592."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b0655","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1111\/all.14794","article-title":"Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation","volume":"76","author":"Klimek","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.imbio.2023.152393_b0660","doi-asserted-by":"crossref","unstructured":"Klingler J, Lambert GS, Itri V, Liu S, Bandres JC, Enyindah-Asonye G , et al. Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals. medRxiv Prepr Serv Heal Sci. 2021;2021.05.11.21256972.","DOI":"10.1101\/2021.05.11.21256972"},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b0665","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/v12080880","article-title":"Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2","volume":"12","author":"K\u00f6rner","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0670","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000520144","article-title":"Thrombotic Microangiopathy Triggered by COVID-19: Case Reports","volume":"146","author":"Korotchaeva","year":"2022","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0675","doi-asserted-by":"crossref","first-page":"e0167121","DOI":"10.1128\/spectrum.01671-21","article-title":"Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability","volume":"10","author":"Kovacs-Kasa","year":"2022","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.imbio.2023.152393_b0680","doi-asserted-by":"crossref","unstructured":"Kowalska D, Ku\u017aniewska A, Senent Y, Tavira B, Inog\u00e9s S, L\u00f3pez-D\u00edaz de Cerio A, et al. C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d. Front Immunol. 2022;13:946522.","DOI":"10.3389\/fimmu.2022.946522"},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0685","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1371\/journal.pone.0000623","article-title":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2","volume":"2","author":"Krarup","year":"2007","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0690","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bbapap.2008.03.020","article-title":"The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen","volume":"1784","author":"Krarup","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102930","article-title":"SARS-CoV-2-encoded ORF8 protein possesses complement inhibitory properties","volume":"299","author":"Kumar","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0700","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s13256-021-03144-2","article-title":"Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports","volume":"15","author":"Kurian","year":"2021","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.imbio.2023.152393_b0705","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684014","article-title":"Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients","volume":"12","author":"Lafon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.815833","article-title":"Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients","volume":"13","author":"Lage","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0715","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/vaccines10030446","article-title":"Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility","volume":"10","author":"Lai","year":"2022","journal-title":"Vaccines."},{"key":"10.1016\/j.imbio.2023.152393_b0720","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.838780","article-title":"SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation","volume":"13","author":"Lamerton","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0725","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1164\/ajrccm\/138.2.368","article-title":"Accentuated formation of the terminal C5b\u20139 complement complex in patient plasma precedes development of the adult respiratory distress syndrome","volume":"138","author":"Langlois","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0090-1229(88)90068-2","article-title":"Complement activation occurs through both classical and alternative pathways prior to onset and resolution of adult respiratory distress syndrome","volume":"47","author":"Langlois","year":"1988","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0735","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1038\/s41598-022-17011-7","article-title":"A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce","volume":"12","author":"Laudanski","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2023.152393_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108555","article-title":"Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19","volume":"219","author":"Laurence","year":"2020","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0745","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ajpath.2022.05.006","article-title":"Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage","volume":"192","author":"Laurence","year":"2022","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0750","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00430-021-00725-2","article-title":"Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality","volume":"211","author":"Leatherdale","year":"2022","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0755","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842473","article-title":"Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19","volume":"13","author":"Leone","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.imbio.2023.152393_b0760","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1017\/S095026882000165X","article-title":"Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19)","volume":"148","author":"Li","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.imbio.2023.152393_b0765","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cytogfr.2020.12.001","article-title":"The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy","volume":"58","author":"Li","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1147","key":"10.1016\/j.imbio.2023.152393_b0770","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/postgradmedj-2020-139070","article-title":"COVID-19: a comparison to the 1918 influenza and how we can defeat it","volume":"97","author":"Liang","year":"2021","journal-title":"Postgrad. Med. J."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b0775","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/vaccines9090974","article-title":"Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination","volume":"9","author":"Lim","year":"2021","journal-title":"Vaccines."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0780","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02278-1","article-title":"Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial","volume":"23","author":"Lim","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.imbio.2023.152393_b0785","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627579","article-title":"The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein\/Kinin System","volume":"12","author":"Lipcsey","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0790","unstructured":"Liu JL, Cao C, Ma QJ. Study on interaction between SARS-CoV N and MAP19. o Yu Fen Zi Mian Yi Xue Za Zhi. 2009;25(9):777-9."},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b0795","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1002\/cti2.1413","article-title":"SARS-CoV-2 triggers complement activation through interactions with heparan sulfate","volume":"11","author":"Lo","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b0800","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1002\/cti2.1413","article-title":"ssssssssSARS-CoV-2 triggers complement activation through interactions with heparan sulfate","volume":"11","author":"Lo","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0805","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jcyt.2021.12.003","article-title":"Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes","volume":"24","author":"Loh","year":"2022","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0810","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13166","article-title":"The Factor H protein family: The switchers of the complement alternative pathway","volume":"313","author":"Lucientes-Continente","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2023.152393_b0815","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837288","article-title":"Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults","volume":"13","author":"Lund Berven","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0820","doi-asserted-by":"crossref","first-page":"e980","DOI":"10.1002\/ctm2.980","article-title":"Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19","volume":"12","author":"Lynch","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b0825","first-page":"253","article-title":"Studies on the polymorphism of the fifth component of complement in laboratory mice","volume":"12","author":"Lynch","year":"1995","journal-title":"Exp. Clin. Immunogenet."},{"issue":"59","key":"10.1016\/j.imbio.2023.152393_b0830","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci. Immunol."},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b0835","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/biomedicines9081003","article-title":"Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients","volume":"9","author":"Macor","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.imbio.2023.152393_b0840","doi-asserted-by":"crossref","unstructured":"Macor P, Durigutto P, Mangogna A, Bussani R, D\u2019Errico S, Zanon M, et al. Multi-organ complement deposition in COVID-19 patients. medRxiv Prepr Serv Heal Sci. 2021; 2021.01.07.21249116.","DOI":"10.1101\/2021.01.07.21249116"},{"key":"10.1016\/j.imbio.2023.152393_b0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b0850","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.clindermatol.2021.07.011","article-title":"The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin","volume":"39","author":"Magro","year":"2021","journal-title":"Clin. Dermatol."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b0855","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40620-020-00858-2","article-title":"Eculizumab treatment for renal failure in a pediatric patient with COVID-19","volume":"33","author":"Mahajan","year":"2020","journal-title":"J. Nephrol."},{"key":"10.1016\/j.imbio.2023.152393_b0860","doi-asserted-by":"crossref","unstructured":"Malaquias MAS, Gadotti AC, Motta-Junior J da S, Martins APC, Azevedo MLV, Benevides APK, et al. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury. Transl Res. 2021;231:55\u201363.","DOI":"10.1016\/j.trsl.2020.11.008"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0865","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13063-022-06219-7","volume":"23","author":"Malchair","year":"2022","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0870","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13063-021-05027-9","article-title":"Evaluation of the efficacy and safety of icatibant and C1 esterase\/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial","volume":"22","author":"Mansour","year":"2021","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0875","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/eji.202048858","article-title":"Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients","volume":"51","author":"Marcos-Jim\u00e9nez","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b0890","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151092","article-title":"Is complement the culprit behind COVID-19 vaccine-related adverse reactions?","volume":"131","author":"Mastellos","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b0895","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/pai.13271","article-title":"The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures","volume":"31","author":"Matricardi","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0900","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1172\/JCI111187","article-title":"Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum","volume":"73","author":"Mayes","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0905","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40121-021-00425-7","article-title":"Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019","volume":"10","author":"McEneny-King","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.imbio.2023.152393_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104717","article-title":"Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection","volume":"89","author":"Medetalibeyoglu","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.imbio.2023.152393_b0915","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671052","article-title":"Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease","volume":"12","author":"Medjeral-Thomas","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103232","article-title":"Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients","volume":"22","author":"Meroni","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b0925","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1007\/s10072-022-05922-2","article-title":"Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab","volume":"43","author":"Mimori","year":"2022","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0930","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jha2.508","article-title":"Adult paroxysmal cold hemoglobinuria following mRNA COVID-19 vaccination","volume":"3","author":"Misawa","year":"2022","journal-title":"EJHaem."},{"issue":"57","key":"10.1016\/j.imbio.2023.152393_b0935","doi-asserted-by":"crossref","first-page":"85569","DOI":"10.1007\/s11356-021-15183-9","article-title":"Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients","volume":"29","author":"Moulana","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.imbio.2023.152393_b0940","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1109\/OJEMB.2020.3014798","article-title":"Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems","volume":"1","author":"Mukund","year":"2020","journal-title":"IEEE open J Eng Med Biol."},{"key":"10.1016\/j.imbio.2023.152393_b0945","first-page":"1","article-title":"Hilar lymphadenopathy, development of tubulointerstitial nephritis, and dense deposit disease following Pfizer-BioNTech COVID-19 vaccination","author":"Nakamura","year":"2022","journal-title":"CEN case reports."},{"key":"10.1016\/j.imbio.2023.152393_b0950","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835156","article-title":"Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19","volume":"13","author":"Niederreiter","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0955","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840137","article-title":"How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment","volume":"13","author":"Nilsson","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664209","article-title":"Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients","volume":"12","author":"Nossent","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b0965","doi-asserted-by":"crossref","unstructured":"O\u2019Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S. A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection. PLoS One. 011;6(3):17377.","DOI":"10.1371\/journal.pone.0017377"},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b0970","doi-asserted-by":"crossref","first-page":"e0155321","DOI":"10.1128\/spectrum.01553-21","article-title":"Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection","volume":"10","author":"Okuya","year":"2022","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.imbio.2023.152393_b0975","doi-asserted-by":"crossref","unstructured":"Pai M, Chan B, Stall NM, Grill A, Ivers N, Maltsev A, et al. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination. 2021; https:\/\/doi.org\/10.47326\/ocsat.2021.02.17.2.0.","DOI":"10.47326\/ocsat.2021.02.17.2.0"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b0980","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/clinchem.2005.061689","article-title":"Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome","volume":"52","author":"Pang","year":"2006","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b0985","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12950-022-00325-8","article-title":"Bystander effect of SARS-CoV-2 spike protein on human monocytic THP-1 cell activation and initiation of prothrombogenic stimulus representing severe COVID-19","volume":"19","author":"Patra","year":"2022","journal-title":"J. Inflamm."},{"issue":"10","key":"10.1016\/j.imbio.2023.152393_b0990","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","article-title":"Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study","volume":"143","author":"Pellegrini","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2023.152393_b0995","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.827146","article-title":"SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation","volume":"13","author":"Perico","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b1000","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594849","article-title":"Complement Activation in Kidneys of Patients With COVID-19","volume":"11","author":"Pfister","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b1005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1099\/0022-1317-42-2-279","article-title":"The neutralization of transmissible gastroenteritis virus by normal heterotypic serum","volume":"42","author":"Pike","year":"1979","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/bjh.17097","article-title":"COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience","volume":"191","author":"Pike","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b1015","first-page":"138","article-title":"COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant","volume":"60","author":"Pinte","year":"2022","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.imbio.2023.152393_b1020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.thromres.2021.10.027","article-title":"COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets","volume":"208","author":"Pitk\u00e4nen","year":"2021","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b1025","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3390\/v13122429","article-title":"Soliris to Stop Immune-Mediated Death in COVID-19 (SOLID-C19)-A Compassionate-Use Study of Terminal Complement Blockade in Critically Ill Patients with COVID-19-Related Adult Respiratory Distress Syndrome","volume":"13","author":"Pitts","year":"2021","journal-title":"Viruses"},{"issue":"3285","key":"10.1016\/j.imbio.2023.152393_b1030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1126\/science.126.3285.1245","article-title":"Complement fixation with mouse hepatitis virus","volume":"126","author":"Pollard","year":"1957","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.imbio.2023.152393_b1035","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/bloodadvances.2021004957","article-title":"Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination","volume":"5","author":"Portuguese","year":"2021","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1040","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.jaci.2021.03.038","article-title":"C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia","volume":"147","author":"Posch","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b1045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/ckj\/sfaa192","article-title":"Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression","volume":"13","author":"Prendecki","year":"2020","journal-title":"Clin. Kidney J."},{"issue":"8","key":"10.1016\/j.imbio.2023.152393_b1050","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.intimp.2006.03.002","article-title":"Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats","volume":"6","author":"Proctor","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imbio.2023.152393_b1055","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.616731","article-title":"Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome","volume":"8","author":"Raghunandan","year":"2020","journal-title":"Front. Pediatr."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b1060","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/cells10123580","article-title":"Pediatric Atypical Hemolytic Uremic Syndrome Advances","volume":"10","author":"Raina","year":"2021","journal-title":"Cells."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2023.152393_b1070","doi-asserted-by":"crossref","unstructured":"Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, May B, et al. Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome. medRxiv Prepr Serv Heal Sci. 2020; 2020.05.05.20092452.","DOI":"10.1101\/2020.05.05.20092452"},{"issue":"10","key":"10.1016\/j.imbio.2023.152393_b1075","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2023.152393_b1080","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2018.00764","article-title":"Complement Component C1q: Historical Perspective of a Functionally Versatile, and Structurally Unusual","volume":"9","author":"Reid","year":"2018","journal-title":"Serum Protein. Front Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b1085","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/pmic.200400897","article-title":"The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome","volume":"4","author":"Ren","year":"2004","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b1090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jmv.1890060309","article-title":"Coronavirus infections of man associated with diseases other than the common cold","volume":"6","author":"Riski","year":"1980","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1095","first-page":"e33938","article-title":"IgA Vasculitis Following COVID-19 Vaccination","volume":"15","author":"Rista","year":"2023","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1100","doi-asserted-by":"crossref","first-page":"0023","DOI":"10.1371\/journal.ppat.0030005","article-title":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice","volume":"3","author":"Roberts","year":"2007","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imr.13131","article-title":"Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases","volume":"313","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2023","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b1110","doi-asserted-by":"crossref","first-page":"e0261113","DOI":"10.1371\/journal.pone.0261113","article-title":"Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study","volume":"16","author":"Ruggenenti","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2023.152393_b1115","doi-asserted-by":"crossref","unstructured":"Safavi F, Gustafson L, Walitt B, Lehky T, Dehbashi S, Wiebold A, et al. Neuropathic symptoms with SARS-CoV-2 vaccination. medRxiv Prepr Serv Heal Sci. 2022; 2022.05.16.22274439.","DOI":"10.1101\/2022.05.16.22274439"},{"key":"10.1016\/j.imbio.2023.152393_b1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108716","article-title":"Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19","volume":"226","author":"Satyam","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b1125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767347","article-title":"SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems","volume":"12","author":"Savitt","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b1130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00277-020-04318-6","article-title":"Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report","volume":"100","author":"Sch\u00fcller","year":"2021","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.imbio.2023.152393_b1135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767376","article-title":"Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge","volume":"12","author":"Senent","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b1140","first-page":"e16383","article-title":"A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study","volume":"13","author":"Shazley","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.imbio.2023.152393_b1145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.630430","article-title":"C-Reactive Protein Triggers Cell Death in Ischemic Cells","volume":"12","author":"Sheriff","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12959-021-00330-6","article-title":"COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab","volume":"19","author":"Shikdar","year":"2021","journal-title":"Thromb. J."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b1155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/imm.13585","article-title":"Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19","volume":"168","author":"Siggins","year":"2023","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b1160","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/jcmm.12667","article-title":"Complement inhibition decreases early fibrogenic events in the lung of septic baboons","volume":"19","author":"Silasi-Mansat","year":"2015","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1165","first-page":"11","article-title":"Autoimmune Haemolytic Anaemia following ChAd Ox 1 nCoV-19 in Haemodialysis","volume":"70","author":"Simon","year":"2022","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.imbio.2023.152393_b1170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663187","article-title":"Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection","volume":"12","author":"Sinkovits","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1175","doi-asserted-by":"crossref","first-page":"19759","DOI":"10.1038\/s41598-022-23806-5","article-title":"Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children","volume":"12","author":"Sinkovits","year":"2022","journal-title":"Sci. Rep."},{"issue":"50","key":"10.1016\/j.imbio.2023.152393_b1180","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1556\/650.2020.32075","article-title":"Age-dependent possible role of contact-activated blood coagulation factor XII as a potential contributor to the \u201cbradykinin storm\u201d in COVID-19 patients","volume":"161","author":"Sipka","year":"2020","journal-title":"Orv. Hetil."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b1185","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/14034948221108548","article-title":"Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway","volume":"50","author":"St\u00e5lcrantz","year":"2022","journal-title":"Scand. J. Public Health"},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1195","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI112506","article-title":"Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates","volume":"77","author":"Stevens","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2023.152393_b1200","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.934270","article-title":"Autoimmune and immunoserological markers of COVID-19 pneumonia: Can they help in the assessment of disease severity","volume":"9","author":"Stjepanovic","year":"2022","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b1205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41590-021-01114-w","article-title":"Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules","volume":"23","author":"Stravalaci","year":"2022","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152393_b1210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","article-title":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection","volume":"49","author":"Sun","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1215","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cid\/ciu887","article-title":"Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys","volume":"60","author":"Sun","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"8674","key":"10.1016\/j.imbio.2023.152393_b1220","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(89)91849-7","article-title":"Association of low levels of mannan-binding protein with a common defect of opsonisation","volume":"2","author":"Super","year":"1989","journal-title":"Lancet (London, England)."},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b1225","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1242\/jcs.179291","article-title":"Complement-mediated \u201cbystander\u201d damage initiates host NLRP3 inflammasome activation","volume":"129","author":"Suresh","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.imbio.2023.152393_b1230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585243","article-title":"The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System","volume":"11","author":"\u015awierzko","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103215","article-title":"The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery","volume":"24","author":"Syrimi","year":"2021","journal-title":"iScience."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jhep.2017.11.010","article-title":"Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil-mediated complement activation","volume":"68","author":"Tang","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imbio.2023.152393_b1245","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molimm.2022.11.010","article-title":"Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis","volume":"152","author":"Thomas","year":"2022","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1250","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.16938","article-title":"C1 esterase inhibitor and the contact system in COVID-19","volume":"190","author":"Thomson","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1255","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152393_b1260","doi-asserted-by":"crossref","first-page":"1032331","DOI":"10.3389\/fimmu.2022.1032331","article-title":"Levels of soluble complement regulators predict severity of COVID-19 symptoms","volume":"13","author":"Tierney","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b1265","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ckj\/sfaa166","article-title":"Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome","volume":"13","author":"Trimarchi","year":"2020","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.imbio.2023.152393_b1270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.molimm.2021.03.021","article-title":"SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection","volume":"135","author":"Tsiftsoglou","year":"2021","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1275","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1111\/aos.14685","article-title":"Age-related macular degeneration and mortality in SARS-CoV-2-infected patients","volume":"99","author":"Tuuminen","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.imbio.2023.152393_b1280","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3389\/fimmu.2020.02072","article-title":"Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System","volume":"11","author":"Urwyler","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04976-x","volume":"22","author":"Urwyler","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.imbio.2023.152393_b1290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molimm.2022.08.008","article-title":"Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression","volume":"150","author":"Urwyler","year":"2022","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2023.152393_b1295","article-title":"Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report","volume":"5","author":"Utebay","year":"2021","journal-title":"Eur Hear journal Case reports."},{"key":"10.1016\/j.imbio.2023.152393_b1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102595","article-title":"Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19","volume":"117","author":"Valenti","year":"2021","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1305","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2500\/aap.2021.42.210083","article-title":"COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications","volume":"42","author":"Veronez","year":"2021","journal-title":"Allergy Asthma Proc."},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b1310","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/JVI.79.3.1595-1604.2005","article-title":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event","volume":"79","author":"Vijgen","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.kint.2020.10.030","article-title":"Atypical HUS relapse triggered by COVID-19","volume":"99","author":"Ville","year":"2021","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b1320","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1325","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cts.13213","article-title":"The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19","volume":"15","author":"Vlaar","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.imbio.2023.152393_b1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108493","article-title":"A plea for the pathogenic role of immune complexes in severe Covid-19","volume":"217","author":"Vuitton","year":"2020","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF03401685","article-title":"Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes","volume":"3","author":"Wallace","year":"1997","journal-title":"Mol. Med."},{"issue":"21","key":"10.1016\/j.imbio.2023.152393_b1340","doi-asserted-by":"crossref","first-page":"14730","DOI":"10.1021\/acs.analchem.0c03301","article-title":"Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer\/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry","volume":"92","author":"Wang","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.imbio.2023.152393_b1345","doi-asserted-by":"crossref","unstructured":"Wang EY, Mao T, Klein J, Dai Y, Huck JD, Liu F, et al. Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv Prepr Serv Heal Sci. 2021;2020.12.10.20247205.","DOI":"10.1101\/2020.12.10.20247205"},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b1350","first-page":"e28","article-title":"The role of C5a in acute lung injury induced by highly pathogenic viral infections","volume":"4","author":"Wang","year":"2015","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.imbio.2023.152393_b1355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2334-9-51","article-title":"Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.imbio.2023.152393_b1360","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1099\/jgv.0.000962","article-title":"CD59 association with infectious bronchitis virus particles protects against antibody-dependent complement-mediated lysis","volume":"98","author":"Wei","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jmii.2020.04.013","article-title":"A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2","volume":"54","author":"Wei","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"7","key":"10.1016\/j.imbio.2023.152393_b1370","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00005373-198807000-00017","article-title":"Complement and the severity of pulmonary failure","volume":"28","author":"Weigelt","year":"1988","journal-title":"J. Trauma"},{"issue":"3","key":"10.1016\/j.imbio.2023.152393_b1375","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2460\/ajvr.1988.49.03.300","article-title":"Neutralization of porcine transmissible gastroenteritis virus by complement-dependent monoclonal antibodies","volume":"49","author":"Woods","year":"1988","journal-title":"Am. J. Vet. Res."},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1380","doi-asserted-by":"crossref","first-page":"e00362","DOI":"10.1128\/msphere.00362-20","article-title":"Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19","volume":"5","author":"Wu","year":"2020","journal-title":"mSphere."},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1385","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/21505594.2020.1816076","article-title":"Exploration of turn-positive RT-PCR results and factors related to treatment outcome in COVID-19: A retrospective cohort study","volume":"11","author":"Xiao","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.imbio.2023.152393_b1390","doi-asserted-by":"crossref","unstructured":"Xie L, Wu Q, Lin Q, Liu X, Lin W, Hao S, et al. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study. Ther Adv Respir Dis. 2020;1 4:1753466620942129.","DOI":"10.1177\/1753466620942129"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1395","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hep.27114","article-title":"C5a\/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2\/fibroleukin expression","volume":"60","author":"Xu","year":"2014","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b1400","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100454","article-title":"Does hereditary angioedema make COVID-19 worse?","volume":"13","author":"Xu","year":"2020","journal-title":"World Allergy Organ. J."},{"issue":"18","key":"10.1016\/j.imbio.2023.152393_b1405","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imbio.2023.152393_b1410","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.2021.279155","article-title":"Complement dysregulation is associated with severe COVID-19 illness","volume":"107","author":"Yu","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.imbio.2023.152393_b1415","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0039.2005.00476.x","article-title":"Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome","volume":"66","author":"Yuan","year":"2005","journal-title":"Tissue Antigens"},{"issue":"9","key":"10.1016\/j.imbio.2023.152393_b1420","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/rccm.202007-2778LE","article-title":"Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19","volume":"202","author":"Zelek","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.imbio.2023.152393_b1425","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang W, Wan C, Cheng G, Yin Y, Cao K, et al. A predictive model for respiratory distress in patients with COVID-19: a retrospective study. Ann Transl Med. 2020;8(23):1585\u20131585.","DOI":"10.21037\/atm-20-4977"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1430","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13054-021-03482-z","article-title":"Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients","volume":"25","author":"Zhang","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.imbio.2023.152393_b1435","article-title":"Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2023.152393_b1440","article-title":"Bioinformatics approach to identify the influences of SARS-COV2 infections on atherosclerosis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.imbio.2023.152393_b1445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145561","article-title":"Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imbio.2023.152393_b1450","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40249-020-00723-1","article-title":"Abnormal immunity of non-survivors with COVID-19: predictors for mortality","volume":"9","author":"Zhao","year":"2020","journal-title":"Infect. Dis. Poverty"},{"issue":"Pt 2","key":"10.1016\/j.imbio.2023.152393_b1455","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1099\/vir.0.81078-0","article-title":"Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients","volume":"87","author":"Zhong","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"17","key":"10.1016\/j.imbio.2023.152393_b1460","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.1128\/JVI.00554-10","article-title":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms","volume":"84","author":"Zhou","year":"2010","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.imbio.2023.152393_b1465","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2990.1991.tb00750.x","article-title":"Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response","volume":"17","author":"Zimprich","year":"1991","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.imbio.2023.152393_b1470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696085","article-title":"Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression","volume":"12","author":"Zinellu","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852300061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852300061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:53:40Z","timestamp":1759251220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129852300061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":294,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S017129852300061X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152393","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152393"}}